Skip to main content
OpenTrials
Completed

NCT Number: NCT01454674

The Vegetable Dose Response Study: Effects of Consumption on Inflammation and Oxidative Stress

The investigators have designed a three dose level, cross-over vegetable feeding study using expertise from nutritional sciences and plant sciences to:

1. Implement a randomized vegetable feeding trial among overweight post- menopausal women 2. Produce, in a controlled environmental setting, vegetable crops which provide a selected variety and quantity of carotenoid and nutrient exposure 3. Assess changes and hopefully demonstrate a significant reduction in oxidant stress and inflammation in this population at risk for developing chronic disease

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–75 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

U of AZ Nutritional Sciences Department

Tucson, Arizona, 85721, United States

About this study

Women were randomly assigned a vegetable feeding dose order of consuming 2,5 & 10 servings/day of vegetables for 3 week periods, with feeding periods separated by 4 week washout periods, during which time a limited number of low biological value fruits and vegetables were eaten.

This research will provide important and relevant information to fill several gaps in our current knowledge including a more thorough description of the oxidant stress and inflammatory status of overweight, postmenopausal women, assessment of the relevant daily "dose" of vegetables necessary to modulate biomarkers of oxidant stress and inflammation in overweight postmenopausal women and evaluation of the association between plasma nutrient and carotenoid levels in relation to changes in oxidant stress and inflammation in this population. Our long-term goal is to reduce chronic disease risk among "at-risk" post-menopausal females.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female;
  • Age 50 to 75 years of age;
  • Target to include 20% minority subjects.
  • Post-menopausal - defined as greater than 12 months without menses; or lab values indicative of post-menopausal status;
  • Waist to hip ratio of > 0.85;
  • Body mass index (BMI) between 25.0 and 45 kg/m2 ;
  • Non-smoker;
  • Reported alcohol intake of < 2 servings daily;
  • Reported stable body weight for previous 6 months;
  • In general good health with no history of cancer (other than non- melanoma skin cancer), diabetes, liver or renal disease;
  • No known allergies to or intolerances of leaf lettuce, tomato, carrots or peppers;
  • Willing and able to successfully complete run-in activities -

Exclusion criteria

  • Morbid obesity (BMI > 45 kg/m2);
  • Medical diagnosis requiring a therapeutic diet (i.e, diabetes, hepatic disease, etc);
  • Smoking history within previous 6 months;
  • Consuming > 5 servings of fruits/vegetables daily prior to study enrollment;
  • Regular use of anti-inflammatory medications;
  • Unwilling to discontinue dietary supplements with the exception of study provided multivitamin and/or calcium supplement;
  • Unwilling to adhere to study protocol including limiting fruit intake to 1 serving per day and excluding vegetable intake other than study provided and allowed vegetables.
  • Participating in greater than 10 hours of regularly scheduled physical activity weekly or participating in vigorous physical activity on a regular basis (i.e. daily running, contact sports, etc) as assessed using a validated physical activity assessment questionnaire.

Treatment and study plan

2, 5 & 10 Vegetable doses

Other

2,5 & 10 serving dose/day combination of fresh lettuce mix, baby carrots, red bell peppers & tomatoes consumed for 3 week intervals

Primary outcomes

  1. Serum high sensitivity c-reactive protein

    Time frame: Change between baseline and 3 weeks

    Change in serum high sensitivity c-reactive protein

  2. Urine Isoprostanes 8-epi-PGF2alpha

    Time frame: Change between baseline and 3 weeks

    Change in Urine Isoprostanes 8-epi-PGF2alpha

Secondary outcomes

  1. Plasma carotenoids

    Time frame: Change between baseline and 3 weeks

    Change in plasma carotenoids.

  2. Physical activity - Arizona Activity Frequency Questionnaire

    Time frame: Change between baseline and 21 weeks

    Change in physical activity.

  3. Body weight

    Time frame: Change between baseline and 3 weeks

    Change in body weight

  4. Waist/hip circumference

    Time frame: Change between baseline and 3 weeks

    Change in waist/hip circumference

  5. Percent body fat

    Time frame: Change between baseline and 3 weeks

    Change in % body fat

  6. Blood pressure

    Time frame: Change between baseline and 21 weeks

    Change in blood pressure

Sponsors and collaborators

Lead sponsor

University of Arizona

Other

Collaborators

  • United States Department of Agriculture (USDA)

Registry information

Important dates

Study start
2007
Primary completion
2010
Study completion
2011
First posted
Oct 19, 2011
Registry last updated
Oct 19, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.